Rafferty Asset Management
RMD icon

Rafferty Asset Management’s ResMed RMD Stock Holding History

Rafferty Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
15,968
+4,711
+42% +$976K 0.01% 534
2026
Q1 		$2.53M Sell
11,257
-4,459
-28% -$1.11M 0.01% 559
2025
Q4 		$3.79M Sell
15,716
-533
-3% -$136K 0.01% 511
2025
Q3 		$4.45M Buy
16,249
+758
+5% +$207K 0.01% 449
2025
Q2 		$4M Buy
15,491
+1,895
+14% +$452K 0.01% 440
2025
Q1 		$3.04M Sell
13,596
-3,054
-18% -$713K 0.01% 475
2024
Q4 		$3.81M Buy
16,650
+693
+4% +$167K 0.01% 466
2024
Q3 		$3.9M Sell
15,957
-11
-0.1% -$2.46K 0.01% 473
2024
Q2 		$3.06M Buy
15,968
+792
+5% +$161K 0.01% 521
2024
Q1 		$3.01M Buy
15,176
+200
+1% +$36.6K 0.01% 587
2023
Q4 		$2.58M Sell
14,976
-354
-2% -$54.4K 0.01% 610
2023
Q3 		$2.27M Buy
15,330
+1,147
+8% +$207K 0.01% 572
2023
Q2 		$3.1M Buy
14,183
+1,020
+8% +$227K 0.02% 518
2023
Q1 		$2.88M Buy
13,163
+566
+4% +$123K 0.02% 518
2022
Q4 		$2.62M Buy
12,597
+4,745
+60% +$1.04M 0.02% 510
2022
Q3 		$1.71M Buy
7,852
+4,303
+121% +$979K 0.02% 544
2022
Q2 		$744K Sell
3,549
-921
-21% -$196K 0.01% 728
2022
Q1 		$1.08M Sell
4,470
-427
-9% -$103K 0.01% 763
2021
Q4 		$1.28M Buy
4,897
+257
+6% +$66.7K 0.01% 787
2021
Q3 		$1.22M Buy
4,640
+1,411
+44% +$386K 0.01% 761
2021
Q2 		$796K Buy
3,229
+72
+2% +$15.1K 0.01% 979
2021
Q1 		$613K Buy
3,157
+139
+5% +$27.9K ﹤0.01% 934
2020
Q4 		$642K Sell
3,018
-22
-0.7% -$4.39K 0.01% 627
2020
Q3 		$521K Sell
3,040
-598
-16% -$110K 0.01% 687
2020
Q2 		$698K Buy
3,638
+2,153
+145% +$352K 0.01% 632
2020
Q1 		$219K Sell
1,485
-2,397
-62% -$382K 0.01% 507
2019
Q4 		$602K Buy
+3,882
New +$560K 0.01% 663

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Rafferty Asset Management's RMD Position: Q2 2026 in Review

Rafferty Asset Management increased its ResMed (RMD) stake by 42% in Q2 2026, buying an estimated $976K and bringing the position to 15,968 shares worth $3.11M. The position accounts for 0.01% of the portfolio, ranked #534.

Rafferty Asset Management first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.45M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Rafferty Asset Management held 15,968 shares of ResMed worth $3.11M as of Q2 2026.
  • Rafferty Asset Management bought 4,711 ResMed shares in Q2 2026, an estimated $976K.
  • ResMed made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #534 holding.
  • Rafferty Asset Management first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
  • Rafferty Asset Management's ResMed position peaked at $4.45M in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.